Comment to 'Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease'

被引：0
|
作者：
Yamamoto, Takayuki [1 ]
Shiraki, Manabu [1 ]
机构：
[1] Yokkaichi Social Insurance Hosp, Ctr Inflammatory Bowel Dis, Yokaichi, Mie 5100016, Japan
来源：
DIGESTIVE AND LIVER DISEASE | 2013年 / 45卷 / 03期
关键词：
D O I：
10.1016/j.dld.2012.08.007
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：264 / 264
页数：1
相关论文
共 50 条
  • [21] Successful desensitization to 6-mercaptopurine in a patient with Crohn's disease
    Mutinga, M
    Castells, M
    Horan, R
    Farraye, FA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (05): : 1383 - 1384
  • [22] Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
    Prefontaine, Eliza
    MacDonald, John K.
    Sutherland, Lloyd R.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (06):
  • [23] Mucormycosis presenting as recurrent gastric perforation in a patient with Crohn's disease on glucocorticoid, 6-mercaptopurine, and infliximab therapy
    Devlin, Shane M.
    Hu, Bing
    Ippoliti, Andrew
    DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (09) : 2078 - 2081
  • [24] Maintenance therapy versus episodic therapy with infliximab for Crohn's disease
    Ghosh, Subrata
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2004, 1 (02): : 80 - 81
  • [25] Maintenance therapy versus episodic therapy with infliximab for Crohn's disease
    Subrata Ghosh
    Nature Clinical Practice Gastroenterology & Hepatology, 2004, 1 : 80 - 81
  • [26] Mucormycosis Presenting as Recurrent Gastric Perforation in a Patient with Crohn’s Disease on Glucocorticoid, 6-Mercaptopurine, and Infliximab Therapy
    Shane M. Devlin
    Bing Hu
    Andrew Ippoliti
    Digestive Diseases and Sciences, 2007, 52 : 2078 - 2081
  • [27] AZATHIOPRINE AND 6-MERCAPTOPURINE IN CROHN DISEASE - A METAANALYSIS
    PEARSON, DC
    MAY, GR
    FICK, GH
    SUTHERLAND, LR
    ANNALS OF INTERNAL MEDICINE, 1995, 123 (02) : 132 - 142
  • [28] Fatal Disseminated Cytomegalovirus Infection Associated With Infliximab and 6-Mercaptopurine Therapy in a Child With Crohn Disease
    Pickering, Olufunke
    Weinstein, Toba
    Rubin, Lorry G.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (06) : 556 - 556
  • [29] Maintenance therapy with azathioprine (AZA)/6-mercaptopurine (6-MP) in Crohn's Disease (CD) reduces the risk of re-operation particularly in smokers
    Papay, Pavel
    Reinisch, Walter
    Ho, Elien
    Grauer, Cornelia
    Lissner, Donata
    Miehsler, Wolfgang
    Dejaco, Clemens
    Vogelsang, Harald
    Novacek, Gottfried
    GASTROENTEROLOGY, 2008, 134 (04) : A640 - A640
  • [30] NK cells are biologic and biochemical targets of 6-mercaptopurine in Crohn's disease patients
    Yusung, Susy
    McGovern, Dermot
    Lin, Lin
    Hommes, Daniel
    Lagishetty, Venu
    Braun, Jonathan
    CLINICAL IMMUNOLOGY, 2017, 175 : 82 - 90
12345